Read More Healthcare Industry News Vector Science & Therapeutics (TSXV: PAIN) targets intratumoral pancreatic cancer drug delivery with new microneedle catheter patent Pancreatic cancer needs better local therapy. Vector Science & Therapeutics is betting its patent strategy can open a new delivery path. bySrinathMay 1, 2026